A new report from the Pharmaceutical Research and Manufacturers of America is highlighting the large volume of cancer medicines and vaccines that are currently being developed, as well as the impact innovations have had on cancer death rates.
Part of the Dennis & Mireille Gillings Foundation's donation will support the SPECTAcolor Biobank, a tumor tissue sample Biobank and biomarker analysis platform for genetic profiling of patients suffering from advanced cancer.
The National Institutes of Health has issued a final NIH Genomic Data Sharing policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while protecting the privacy of research participants.
Recurrence of hormone-related breast cancer was cut by half in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs, according to data published last week in Cancer Research, a journal of the American Association for Cancer Research.
The National Institutes of Health have awarded a University of Rhode Island pharmacy professor a $1.3 million grant to further study a new class of inorganic nanoparticles that target primary cancer and help control the disease’s spread and recurrence.
Giant Food of Landover, Md., presented its first-ever Giant Food NextGen Award for Children's Cancer Research this week, created for young investigators committed to pursuing a long-term career in pediatric oncology research.
Depend "boldly" re-invited Americans to join The Great American Try On and announced new and expanded celebrity partnerships designed to help give the millions of people living with bladder control issues the confidence to enjoy an active lifestyle.
Increasing one's caffeinated coffee intake could lower one's risk of developing basal cell carcinoma — which is considered the most common form of skin cancer — according to a study published in Cancer Research, a journal of the American Association for Cancer Research.
PharmaCline on Thursday announced it has secured the worldwide rights for drug delivery technology and existing antibiotic products from Phillips Co. that will enable production of a well-tolerated and broad-spectrum topical antibiotic.